Patient education materials (PEMs) sit at the intersection of public health, regulatory compliance, and healthcare communication. Regulators expect them to inform patients without misleading claims, while clinicians rely on them to support adherence and informed decision-making. When designed well, PEMs improve outcomes, reduce medication errors, and strengthen patient trust.

Yet most educational content fails basic comprehension standards. Studies consistently show that patient materials often exceed recommended reading levels. For example, research evaluating cardiovascular education content found average readability around grade 9–12, far above the recommended 6th-grade reading level suggested by major health authorities.

Regulators and health literacy experts increasingly emphasize clear communication, standardized formats, and evidence-based messaging. Pharmaceutical companies, hospitals, and public health agencies must therefore build systematic processes to ensure their patient education materials meet compliance requirements.

This guide explains how to create compliant patient education materials using regulatory guidance, health literacy research, and industry best practices.

Why Patient Education Materials Matter

Healthcare systems increasingly emphasize patient engagement and shared decision-making. Clear educational materials support that shift.

Impact on health outcomes

Evidence links high-quality patient education to improved clinical outcomes:

Better medication adherence
Reduced hospital readmissions
Increased preventive care uptake
Improved patient satisfaction scores

However, literacy barriers remain widespread.

More than one-third of patients demonstrate inadequate health literacy in some clinical populations.
Many patient resources exceed the reading ability of average adults.

When patients cannot understand instructions, treatment errors increase. Misunderstood medication directions represent a major driver of preventable adverse events.

For pharmaceutical companies, ineffective education also increases regulatory risk. Misleading claims, unbalanced risk disclosure, or incomplete safety information can trigger enforcement actions.

The Regulatory Framework for Patient Education Materials

Creating compliant materials requires understanding the regulatory ecosystem governing patient communication.

FDA requirements for patient-facing materials

In the United States, the Food and Drug Administration regulates many forms of patient information, including:

Medication Guides
Patient Package Inserts
Instructions for Use
Direct-to-consumer advertising
Risk communication materials

These materials must:

Present benefits and risks accurately
Avoid misleading claims
Align with approved labeling
Maintain fair balance between efficacy and safety

Regulators also push toward plain-language communication to improve comprehension.

The FDA has proposed Patient Medication Information (PMI) as a standardized one-page document summarizing essential drug information, including indications, risks, and usage instructions.

If finalized, PMI could reshape how pharmaceutical companies present patient information by requiring simplified formats and clearer messaging.

Other regulatory frameworks

Beyond FDA oversight, several additional standards apply.

Federal Trade Commission (FTC)

The FTC regulates deceptive marketing practices, including misleading health claims.

Health literacy standards

Organizations promoting health communication standards include:

National Institutes of Health
American Medical Association
Centers for Disease Control and Prevention

These groups recommend:

Sixth-grade readability level
Plain language
Visual aids
Actionable instructions

International guidelines

Pharmaceutical companies operating globally must also comply with:

European Medicines Agency (EMA) patient information leaflets
UK MHRA patient information guidelines
Health Canada plain language labeling initiative

Global compliance programs typically align messaging across jurisdictions while adapting to local regulatory requirements.

Core Principles of Compliant Patient Education

Effective patient education materials share several foundational characteristics.

1. Accuracy and scientific integrity

All information must align with:

Approved labeling
Clinical trial evidence
Regulatory submissions

Companies must avoid:

Overstating efficacy
Downplaying risks
Promoting off-label uses

Medical, legal, and regulatory teams typically review content through a formal approval process.

2. Fair balance

Fair balance represents a central regulatory requirement.

Educational materials must present:

Benefits
Risks
Limitations of treatment

Content should not emphasize positive outcomes while minimizing adverse effects.

3. Health literacy

Health literacy refers to the ability to obtain, understand, and use health information.

Experts recommend writing patient materials at a sixth-grade reading level to ensure accessibility.

However, research shows most patient resources exceed that threshold.

One systematic review found average readability between 8.8 and 14.8 grade levels, significantly higher than recommended standards.

Lowering complexity improves comprehension and treatment adherence.

4. Actionability

Effective materials tell patients what to do.

For example:

“Take this medication with food.”
“Call your doctor if you experience chest pain.”

Actionable guidance improves health outcomes more than purely informational content.

Step-by-Step Process to Create Compliant Patient Education Materials

Developing compliant materials requires structured collaboration across multiple teams.

Step 1: Define the target audience

Start with audience analysis.

Key factors include:

Age demographics
Education level
Language preferences
Cultural considerations
Disease knowledge

Patients newly diagnosed with a condition require different information than experienced patients managing chronic disease.

Audience segmentation helps ensure content relevance.

Step 2: Align with approved medical information

Before drafting, teams should gather authoritative sources.

Typical references include:

FDA-approved prescribing information
Clinical trial publications
Consensus treatment guidelines
Safety communications

Medical affairs teams usually verify the scientific accuracy of content.

No claims should appear in patient materials unless supported by approved evidence.

Step 3: Use plain language

Plain language improves comprehension without sacrificing accuracy.

Strategies include:

Short sentences
Common vocabulary
Active voice
Clear structure

Example:

Instead of
“Administration of the medication should occur concomitantly with food.”

Write
“Take this medicine with food.”

This approach reduces cognitive load and improves recall.

Step 4: Maintain appropriate readability

Teams should test readability using established tools:

Flesch-Kincaid Grade Level
SMOG Index
Gunning Fog Index

Studies consistently show that simplifying educational materials can dramatically improve readability and comprehension.

Organizations should set internal standards requiring readability testing before publication.

Step 5: Structure content clearly

Patients process information better when materials follow predictable structures.

Effective layouts typically include:

Headings and subheadings

Break information into sections such as:

What this medicine treats
How to take it
Possible side effects
When to call your doctor

Bullet points

Bulleted lists improve readability and reduce cognitive effort.

White space

Clean layouts help readers scan content quickly.

Step 6: Use visuals strategically

Visual communication significantly improves understanding.

Research shows images linked to written instructions increase comprehension and recall.

Examples include:

Diagrams explaining disease processes
Step-by-step medication instructions
Infographics summarizing risk information

However, visuals must support—not replace—accurate written information.

Regulatory reviewers often evaluate images to ensure they do not imply exaggerated benefits.

Step 7: Ensure balanced risk communication

Risk communication remains one of the most regulated aspects of patient education.

Materials must clearly disclose:

Common side effects
Serious safety risks
Contraindications
Drug interactions

Companies must avoid minimizing risk language through design choices.

For example:

Do not place risk information in small fonts
Avoid burying safety information in dense paragraphs

Risk sections should remain easy to locate and read.

Step 8: Validate understandability

Testing improves quality.

Common evaluation methods include:

Patient usability testing

Organizations recruit representative patients to review materials and answer comprehension questions.

Health literacy assessment tools

Tools include:

Suitability Assessment of Materials (SAM)
Patient Education Materials Assessment Tool (PEMAT)

These frameworks measure:

Clarity
Actionability
Cultural relevance

Step 9: Conduct Medical-Legal-Regulatory (MLR) review

Most pharmaceutical companies require formal MLR review before releasing patient materials.

Typical review participants include:

Medical affairs
Regulatory affairs
Legal counsel
Compliance teams

MLR committees evaluate:

Accuracy
Risk disclosure
Alignment with labeling
Promotional implications

Documentation of this process helps companies demonstrate compliance during regulatory audits.

Step 10: Monitor and update materials

Healthcare knowledge evolves quickly.

Companies should review materials regularly to reflect:

Updated clinical evidence
Labeling changes
Safety communications

Failure to update outdated content can create compliance risks.

Best Practices for Digital Patient Education

Digital health communication introduces additional compliance challenges.

Accessibility standards

Online materials must comply with accessibility standards such as:

WCAG guidelines
Screen reader compatibility
Mobile responsiveness

Accessibility supports patients with disabilities and reduces legal risk.

Multimedia education

Video and interactive tools often improve engagement.

Healthcare providers increasingly combine formats:

Written guides
Short educational videos
Interactive symptom checkers

This approach accommodates different learning styles.

Common Compliance Risks in Patient Education

Regulators frequently identify similar issues in patient-facing materials.

Misleading benefit claims

Examples include:

Overstating clinical effectiveness
Using selective clinical trial data
Presenting anecdotal success stories

Educational materials should avoid promotional tone.

Inadequate risk disclosure

Risk information must appear prominently and clearly.

Common mistakes include:

Small fonts
Hidden footnotes
Incomplete side-effect descriptions

Off-label information

Patient education must remain within approved indications.

Even educational context cannot promote unapproved uses.

Poor readability

Materials written at high reading levels exclude many patients and may undermine informed consent.

Integrating Patient Education into Compliance Programs

Pharmaceutical companies increasingly embed health literacy into corporate compliance strategies.

Key components include:

Standard operating procedures (SOPs)

Companies should establish SOPs covering:

Content development
Readability standards
MLR review workflows
Version control

Training programs

Employees involved in patient communication should receive training on:

Regulatory requirements
Health literacy principles
Risk communication

Content governance

Large organizations often maintain centralized content libraries to ensure consistency across materials.

The Role of Technology in Patient Education

New technologies are transforming how organizations create patient materials.

Artificial intelligence

AI tools can:

Simplify medical language
Improve readability
Generate multilingual content

Recent research shows large language models can help reduce reading complexity in patient communications.

However, human oversight remains essential to ensure accuracy and regulatory compliance.

Natural language processing

Researchers also develop machine learning tools that translate complex medical terminology into plain language explanations.

These technologies may accelerate patient-friendly content creation.

Future Trends in Patient Education Compliance

Several developments will shape patient communication over the next decade.

Standardized patient information formats

Regulators increasingly favor standardized formats such as FDA’s proposed PMI.

These formats:

Reduce information overload
Improve comprehension
Create consistency across medicines

Digital health ecosystems

Patient education will increasingly integrate with:

Electronic health records
Patient portals
Telehealth platforms

Personalized digital education may replace generic handouts.

Real-world evidence

Healthcare organizations increasingly evaluate patient education using outcome data such as adherence rates and health literacy improvements.

Key Checklist for Creating Compliant Patient Education Materials

Healthcare organizations can use the following checklist during development.

Content accuracy

Align with approved labeling
Verify clinical claims
Cite authoritative sources

Health literacy

Target sixth-grade reading level
Use plain language
Avoid medical jargon

Structure

Use headings and bullet points
Keep paragraphs short
Highlight actionable steps

Visual design

Include supportive visuals
Avoid misleading imagery
Maintain clear typography

Risk communication

Present risks prominently
Ensure fair balance
Avoid minimizing side effects

Compliance review

Conduct MLR approval
Document review decisions
Maintain version control

Conclusion

Patient education materials represent a critical but often overlooked component of healthcare communication. When written poorly, they confuse patients and increase safety risks. When designed effectively, they empower patients to make informed decisions and follow treatment plans.

Regulators increasingly expect organizations to apply health literacy principles, transparent risk communication, and rigorous review processes. Evidence shows that most patient materials still exceed recommended reading levels, creating barriers to understanding.

Pharmaceutical companies, healthcare providers, and public health agencies must therefore adopt structured development processes that prioritize:

Plain language
Scientific accuracy
Regulatory compliance
Patient comprehension

Organizations that invest in compliant, patient-centered education will strengthen trust, improve health outcomes, and reduce regulatory risk.

References

National Institutes of Health readability research on patient materials
https://pubmed.ncbi.nlm.nih.gov/28571004/
JAMA Otolaryngology systematic review on health literacy in patient education materials
https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/2819695
American Medical Association readability recommendation discussion
https://www.sciencedirect.com/science/article/pii/S2405579424000111
CDC Health Literacy Guidance for Developing Materials
https://www.cdc.gov/health-literacy/php/develop-materials/guidance-standards.html
Readability of online patient education resources research
https://pubmed.ncbi.nlm.nih.gov/25147778/
Improving readability of patient education materials study
https://pubmed.ncbi.nlm.nih.gov/27487960/
Research on simplifying FDA patient communications using AI
https://pubmed.ncbi.nlm.nih.gov/38823007/